Professional Documents
Culture Documents
Tests are performed rapidly and easily by using a reagent strip (e.g. Glucostix) where a minute drop of capillary blood is obtained from the clients digits (finger or toe), earlobe or heel. On the condition where the patient has all the equipments this test can be performed at home, office, hospitals, clinics and even when travelling. Purpose 1. 2. 3. 4. Blood glucose tests detect blood glucose levels in people with the following conditions: Diabetes Mellitus (Type 1, Type 2) Gestational diabetes Neonatal hypoglycemia Diabetic Coma During the test, a portable blood glucose meter (e.g. Glucometer or One Touch) is used to give numerical data or measurement of a patients serum glucose level by inserting the blood stained plastic strip. Some meters are installed with memory application helpful in storing the sequence of test results obtained for easy evaluation.
Paraphernalia 1. 2. 3. 4. 5. 6. 7. Reagent strips or test strip Clean Gloves Alcohol pads Lancets or lancing device Portable glucose meter Watch (with second hand) Pen and Logbook for documentation Procedure Identify the patient by asking the patient to state his/her name. Also check the clients identification band. ( confirm patients identity using two patient identifiers, based on the hospital protocol) Explain the procedure to the patient or parents (if patient is a child) to gain cooperation. Choose the puncture site. For adults and children fingertips and earlobe can be use. For infants, the tip of the great toe or heel can be the site of puncture. Wash hands and don clean gloves. If glucometer is used, load the strip into the device beforehand. Swab alcohol pad to the chosen puncture site. Use sterile/clean gauze to dry it thoroughly. Piecing the skin with a wet skin (alcohol) allows the chemical to pass through the outer layer of the skin thus, causing the procedure more painful and uncomfortable. To collect a blood sample, position the lancet (pricking needle) at the side of the site. To minimize pain and patients anxiety pierce the skin sharply and briefly. This technique also increases blood flow. For better results, some agencies are using a lancing device (mechanical blood-letting device) wherein the lancets are simply loaded in the spring of the equipment.
1. 2.
3. 4. 5. 6.
7.
(Its like using a spring-loaded pen, once you click the button the spring releases the lancet and immediately retracts it after piercing the skin). However, be sure to load an unused lancet
before using to prevent spread of blood-transmitted diseases. 8. 9. 10. 11. 12. 13. 14. 1. 2. 3. 4. Dont squeeze the puncture site to prevent diluting the sample with fluids from tissues. Cover the entire patch of strip with blood. Place gauze over the punctured area and briefly apply pressure until the bleeding stops. Ask the parents of a child to do this. If using a reagent strip, leave the blood on the strip for 1 minute (60 seconds). And watch the color change on the strip while comparing it to the standardized color chart of the product container. If glucometer is used, simply follow the manufacturers instruction. Apply an adhesive bandage once the bleeding on the puncture site has stopped. Remove gloves and record the resulting glucose level from the digital display for glucometer or from the color of reagent strip to the standardized chart. Common Errors in Blood Glucose Monitoring Dropping a very small amount of blood Inappropriate timing ( the test is usually performed before meals and at bedtime, or whenever hypoglycemia or hyperglycemia occurs) Squeezing the puncture site too hard allowing tissue fluids to mix with the sample Improper maintenance of glucometers (dust or blood accumulation on the digital display) images from pennmedicine.org, mdconsult.com, odessaregionalmedicalcenter.com
Registration for WikiConference India 2011, Mumbai is now open. Click here to register.
Blood glucose testing, showing the size of blood drop required by modern meters. MeSH D015190
Blood glucose monitoring is a way of testing the concentration of glucose in the blood (glycemia). Particularly important in the care of diabetes mellitus, a blood glucose test is performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. Different manufacturers use different technology, but most systems measure an electrical characteristic, and use this to determine the glucose level in the blood. Healthcare professionals advise patients with diabetes on the appropriate monitoring regime for their condition. Most people with Type 2 diabetes test at least once per day. Diabetics who use insulin (all Type 1 diabetes and many Type 2s) usually test their blood sugar more often (3 to 10 times per day), both to assess the effectiveness of their prior insulin dose and to help determine their next insulin dose. Improved technology for measuring blood glucose is rapidly changing the standards of care for all diabetic people.
Contents
1 Purpose 2 Blood glucose meters 3 Continuous glucose monitoring 4 Glucose sensing bio-implants 5 Non-invasive technologies 6 Effectiveness 7 Blood glucose monitoring recommendations 8 References 9 See also
[edit] Purpose
Blood glucose monitoring reveals individual patterns of blood glucose changes, and helps in the planning of meals, activities, and at what time of day to take medications.[1] Also, testing allows for quick response to high blood sugar (hyperglycemia) or low blood sugar (hypoglycemia). This might include diet adjustments, exercise, and insulin (as instructed by the health care provider).[1]
Four generations of blood glucose meter, c. 19932005. Sample sizes vary from 30 to 0.3 l. Test times vary from 5 seconds to 2 minutes (modern meters are typically below 15 seconds).
A blood glucose meter is an electronic device for measuring the blood glucose level. A relatively small drop of blood is placed on a disposable test strip which interfaces with a digital meter. Within several seconds, the level of blood glucose will be shown on the digital display. Needing only a small drop of blood for the meter means that the time and effort required for testing is reduced and the compliance of diabetic people to their testing regimens is improved. Although the cost of using blood glucose meters seems high, it is believed to be a cost benefit relative to the avoided medical costs of the complications of diabetes. Recent advances include:
'alternate site testing', the use of blood drops from places other than the finger, usually the palm or forearm. This alternate site testing uses the same test strips and meter, is practically pain free, and gives the real estate on the finger tips a needed break if they become sore. The disadvantage of this technique is that there is usually less blood flow to alternate sites, which prevents the reading from being accurate when the blood sugar level is changing. 'no coding' systems. Older systems required 'coding' of the strips to the meter. This carried a risk of 'miscoding', which can lead to inaccurate results. Two
approaches have resulted in systems that no longer require coding. Some systems are 'autocoded', where technology is used to code each strip to the meter. And some are manufactured to a 'single code', thereby avoiding the risk of miscoding. 'multi-test' systems. Some systems use a cartridge or a disc containing multiple test strips. This has the advantage that the user doesn't have to load individual strips each time, which is convenient and can enable quicker testing. 'downloadable' meters. Most newer systems come with software that allows the user to download meter results to a computer. This information can then be used, together with health care professional guidance, to enhance and improve diabetes management. The meters usually require a connection cable, unless they are designed to work wirelessly with an insulin pump, or are designed to plug directly into the computer.
Continuous glucose monitors measure the glucose level of interstitial fluid. Shortcomings of CGM systems due to this fact are:
continuous systems must be calibrated with a traditional blood glucose measurement (using current technology) and therefore require both the CGM system and occasional "fingerstick" glucose levels in interstitial fluid lag temporally behind blood glucose values
Patients therefore require traditional fingerstick measurements for calibration (typically twice per day) and are often advised to use fingerstick measurements to confirm hypo- or hyperglycemia before taking corrective action. The lag time discussed above has been reported to be about 5 minutes.[2][3][4] Anecdotally, some users of the various systems report lag times of up to 1015 minutes. This lag time is insignificant when blood sugar levels are relatively consistent. However, blood sugar levels, when changing rapidly, may read in the normal range on a CGM system while in reality the patient is already experiencing symptoms of an out-of-range blood glucose value and may require treatment. Patients using CGM are therefore advised to consider both the absolute value of the blood glucose level given by the system as well as any trend in the blood glucose levels. For example, a patient using CGM with a blood glucose of 100 mg/dl on their CGM system might take no action if their blood glucose has been consistent for several readings, while a patient with the same blood glucose level but whose blood glucose has been dropping steeply in a short period of time might be advised to perform a fingerstick test to check for hypoglycemia.
Continuous monitoring allows examination of how the blood glucose level reacts to insulin, exercise, food, and other factors. The additional data can be useful for setting correct insulin dosing ratios for food intake and correction of hyperglycemia. Monitoring during periods when blood glucose levels are not typically checked (e.g. overnight) can help to identify problems in insulin dosing (such as basal levels for insulin pump users or long-acting insulin levels for patients taking injections). Monitors may also be equipped with alarms to alert patients of hyperglycemia or hypoglycemia so that a patient can take corrective action(s) (after fingerstick testing, if necessary) even in cases where they do not feel symptoms of either condition. While the technology has its limitations, studies have demonstrated that patients with continuous sensors experience less hyperglycemia and also reduce their glycosylated hemoglobin levels.[5][6]
[7][8]
Currently, continuous blood glucose monitoring is not automatically covered by health insurance in the United States in the same way that most other diabetic supplies are covered (e.g. standard glucose testing supplies, insulin, and even insulin pumps). However, an increasing number of insurance companies do cover continuous glucose monitoring supplies (both the receiver and disposable sensors) on a case-by-case basis if the patient and doctor show a specific need. The lack of insurance coverage is exacerbated by the fact that disposable sensors must be frequently replaced. Some sensors have been U.S. Food and Drug Administration (FDA) approved for 7and 3-day use, though some patients wear sensors for longer than the recommended period) and the receiving meters likewise have finite lifetimes (less than 2 years and as little as 6 months). This is one factor in the slow uptake in the use of sensors that have been marketed in the United States. The principles, history and recent developments of operation of electrochemical glucose biosensors are discussed in a chemical review by Joseph Wang.[9]
Some new technologies to monitor blood glucose levels will not require access to blood to read the glucose level. Non-invasive technologies include near IR detection, ultrasound and dielectric spectroscopy. These will free the person with diabetes from finger sticks to supply the drop of blood for blood glucose analysis. Most of the non-invasive methods under development are continuous glucose monitoring methods and offer the advantage of providing additional information to the subject between the conventional finger stick, blood glucose measurements and over time periods where no finger stick measurements are available (i.e. while the subject is sleeping).
[edit] Effectiveness
For patients with diabetes mellitus type 2, the importance of monitoring and the optimal frequency of monitoring are not clear. There is no evidence that better HbA1c monitoring leads
to better patient outcomes in actual practice.[10]. One randomized controlled trial found that selfmonitoring of blood glucose did not improve the HbA1c among "reasonably well controlled noninsulin treated patients with type 2 diabetes".[11]. A recent study found that a treatment strategy of intensively lowering blood sugar levels (below 6%) in patients with additional cardiovascular disease risk factors poses more harm than benefit.[12] For type 2 diabetics who are not on insulin, exercise and diet are the best tools. Blood glucose monitoring is, in that case, simply a tool to evaluate the success of diet and exercise. But those with type 2 who use insulin need to monitor their blood sugar just as frequently as those with type 1.
[edit] References
1. ^ a b MedlinePlus > Blood glucose monitoring Update Date: 6/17/2008. Updated by:
Elizabeth H. Holt, MD, PhD. In turn citing: American Diabetes Association. Standards of medical care in diabetes -- 2008. Diabetes Care. 2008;31:S12-S54.
3. ^ Steil, G.M., Rebrin, K. Mastrototaro,J., Bernaba, B., and Saad, M.F. Determination of
Plasma Glucose During Rapid Glucose Excursions with a Subcutaneous Glucose Sensor. Diabet. Technol. Ther. 2003, 5: 27-31
4. ^ Wilhelm, B., Forst, S., Weber, M.M., Larbig, M., Pftzner, A., and Forst, T. Evaluation
of CGMS During Rapid Blood Glucose Changes in Patients with Type 1 Diabetes. Diabet. Technol. Ther. , 2006, 8: 146-155
5. ^ Garg, S., Zisser H., Schwartz, S., Baile, T., Kaplan, R., Ellis, S., and Jovanovic, L.
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor. Diabetes Care, 2006. 29:44-50
6. ^ Deiss, D., Bolinder, J., Riveline, J-P., Battelino, T., Bose, E., Tubiana-Rufi, N., Kerr,
D., and Phillip, M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care, 2006. 29 (12): 27302732
7. ^ Mastrototaro, J.J., Cooper, K.W., Soundararajan, G., Sanders, J.B., and Shah, R.B.
Adv Ther. 2006 Sep-Oct;23(5):725-32
8. ^ Relationship of fasting and hourly blood glucose levels to HbA1c values: safety,
accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Garg, S. and Jovanovic, L. Diabetes Care 2006 Dec;29(12):2644-9
9. ^ Electrochemical Glucose Biosensors 10. ^ Sidorenkov G, Haaijer-Ruskamp FM, de Zeeuw D, Bilo H, Denig P. (June 2011).
"Relation between quality-of-care indicators for diabetes and patient outcomes: a systematic literature review". Med Care Res Rev 68 (3): 26389. doi:10.1177/1077558710394200. PMID 21536606.
11. ^ Farmer A, Wade A, Goyder E, et al. (2007). "Impact of self monitoring of blood
glucose in the management of patients with non-insulin treated diabetes: open
parallel group randomised trial". BMJ 335 (7611): 132. doi:10.1136/bmj.39247.447431.BE. PMC 1925177. PMID 17591623. http://www.pubmedcentral.nih.gov/articlerender.fcgi? tool=pmcentrez&artid=1925177.
12. ^ Gerstein, H. C., M. E. Miller, et al. (2008). "Effects of intensive glucose lowering in
type 2 diabetes". New England Journal of Medicine, the 358 (358(24)): 254559. doi:10.1056/NEJMoa0802743. PMID 18539917.
Types of diabetes
Prediabetes (Impaired fasting glucose, Impaired glucose tolerance) Type 1 Type 1.5 Type 2 MODY NDM (Transient, Permanent) Diabetes and pregnancy: Gestational diabetes
Blood tests
Diabetes management
Complications/pro gnosis
Diabetic comas (Diabetic hypoglycemia, Diabetic ketoacidosis, Nonketotic hyperosmolar) Diabetic angiopathy Diabetic foot (ulcer, neuropathic arthropathy) Diabetic myonecrosis Diabetic nephropathy Diabetic neuropathy Diabetic retinopathy Diabetic cardiomyopathy Diabetic dermadrome (Diabetic dermopathy, Diabetic bulla, Diabetic cheiroarthropathy, Neuropathic ulcer)
Lines of research
M: END
Glucose meter
anat/phys/devp/horm
noco(d)/cong/tumr, sysi/epon
Retrieved from "http://en.wikipedia.org/w/index.php? title=Blood_glucose_monitoring&oldid=453557674" View page ratings Rate this page
Objective
Complete
Well-written
It is part of my profession
Submit ratings Saved successfully Your ratings have not been submitted yet
Categories: Blood tests Diabetes Insulin therapies Log in / create account Article Discussion
Variants Views
Actions Search
Top of Form
Special:Search
Search
Bottom of Form
Navigation
Main page Contents Featured content Current events Random article Donate to Wikipedia Help About Wikipedia Community portal Recent changes Contact Wikipedia What links here
Interaction
Toolbox
Related changes Upload file Special pages Permanent link Cite this page Rate this page Create a book Download as PDF Printable version Svenska This page was last modified on 2 October 2011 at 17:34. Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. See Terms of use for details. Wikipedia is a registered trademark of the Wikimedia Foundation, Inc., a nonprofit organization. Contact us Privacy policy About Wikipedia Disclaimers Mobile view
Print/export
Languages